Dr. Tashima is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1125 N Main St
Providence, RI 02904Phone+1 401-793-2928Fax+1 508-324-7777
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1991 - 1995
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
- RI State Medical License 1995 - 2026
- CT State Medical License 2023 - 2025
- MA State Medical License 1995 - 2025
- NY State Medical License 1990 - 1992
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2003
Clinical Trials
- Optimizing Treatment for Treatment-Experienced, HIV-Infected People Start of enrollment: 2008 Jan 01
- Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy Start of enrollment: 2009 May 01
- Computer MI for Tobacco Quitline Engagement in Smokers Living With HIV Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 202 citationsImpact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected IndividualsDavid B. Clifford, Scott R. Evans, Yijun Yang, Edward P. Acosta, Karl Goodkin
Annals of Internal Medicine. 2005-11-15 - 44 citationsIncident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical TrialsLynn E. Taylor, Marisa Holubar, Kunling Wu, Ronald J. Bosch, David L. Wyles
Clinical Infectious Diseases. 2011-03-15 - 28 citationsChange in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.Cecilia M. Shikuma, Heather J. Ribaudo, Yu Zheng, Roy M. Gulick, William A. Meyer
AIDS Research and Human Retroviruses. 2011-05-04
Press Mentions
- Will the COVID-19 Vaccine Require a Booster? Local Doctor Says More Data Is NeededJune 28th, 2021
- ‘I Think Its Fantastic’: RI Doctor Involved in Novavax Vaccine TrialJune 14th, 2021
- States Cautiously Re-Roll Out J&J Vaccines Amid More Possible Clot CasesApril 28th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: